ImmunologybioRxiv
BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection but recognition of mutant viruses is up to 10-fold reduced
M. Mohsen, M. F. Bachmann, M. Vogel…·X. Chang
This study compares antibody recognition of SARS-CoV-2 variants by natural infection and BNT162b2 vaccination, finding improved but reduced cross-reactivity against certain mutants.
DOI 10.1111/all.14893